# A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers

> **NCT00516945** · NA · COMPLETED · sponsor: **Hospital Authority, Hong Kong** · enrollment: 110 (estimated)

## Conditions studied

- Hepatitis B
- Neoplasms

## Interventions

- **DRUG:** Lamivudine

## Key facts

- **NCT ID:** NCT00516945
- **Lead sponsor:** Hospital Authority, Hong Kong
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-09
- **Primary completion:** —
- **Final completion:** 2008-06
- **Target enrollment:** 110 (ESTIMATED)
- **Last updated:** 2013-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00516945

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00516945, "A Study to Investigate Whether the Immediate Use or Deferred Use of an Anti-viral Drug Lamivudine Will Help to Better Safe-guard the Delivery of Chemotherapy in Patients With Cancer Who Are Also Hepatitis B Carriers". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00516945. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*